Volume 17, Number 6—June 2011
Dispatch
Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
Diana Averbuch, Carlos Hidalgo-Grass, Allon E. Moses, Dan Engelhard, and Ran Nir-Paz
Table
Clinical information of patients positive for Mycoplasma pneumoniae, according to macrolide resistance genotype, Israel, 2010
| Characteristic | Macrolide-sensitive M. pneumoniae, n = 19* | Macrolide-resistant M. pneumoniae, n = 9 |
|---|---|---|
| Mean age, y, ± SD | 7 ± 14.98 | 9 ± 8.39 |
| >21 |
3 |
1 |
| Admission, mean d, ± SD | 4 ± 6.6 | 3 ± 8.2 |
| Pneumonia confirmed by chest radiograph |
16 |
9 |
| Male/female | 6/13 | 4/5 |
| Ethnicity (Arab/Jewish) |
5/14 |
1/8 |
| Complications† | 3 | 0 |
| Concurrent conditions‡ |
4 |
2 |
| Prior antibiotic use | 9 | 6 |
| Prior macrolide use | 3 | 2 |
*Values are no. patients except as indicated. Clinical data were not available for 2 patients.
†Two patients had Stevens-Johnson syndrome, and Still’s disease developed in 1 patient.
‡Four patients had asthma, 1 had metabolic syndrome with cardiomyopathy, and 1 had carcinoma of the pancreas.
1These authors contributed equally to this article.
Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.